Martin Midstream Partners: A 9% Yielder I Plan To Add To My Income Portfolio On Next Sell-Off

It appears from pre-market futures that the trading week will open on a down note after Friday's large rally on low volume. I will be using any pullback to add to my income portfolio by adding another 9% yielder in the energy MLP space, Martin Midstream Partners (NASDAQ:MMLP). This entity has sold off more than 10% recently along with other high yielding entities as well as an announcement that it would raise additional funding by pricing new units. MMLP is now offering a nice entry point at $31 a share.

Martin Midstream Partners L.P collects, transports, stores, and markets petroleum products and by-products in the United States Gulf Coast region. The company owns or operates 27 marine shore based terminal facilities and 12 specialty terminal facilities among other assets.

Yield & Distribution Growth:

  • MMLP yields a robust 9.8% at current price levels.
  • It is one of Dividend Channel's top ten yield investments right now.
  • The entity has consistently grown its distribution payouts by a few pennies more a quarter per year over the last decade. Distribution has slowed over the last few years (See Chart). However, given its growth prospects and streamlining efforts (see below), I think these distribution payouts will accelerate in the years ahead.

Valuation, Growth, Catalysts & Analyst Opinion:

  • Only three analysts cover MMLP. They all have price targets above the current price and are packed into a tight range (Low Target: $35.50, High Target $36).
  • The company is using divestitures to reduce its exposure to natural gas gathering and processing. Martin will be able to focus more on its oil storage, sulfur services and marine transport businesses which will help to streamline the firm.
  • Revenue growth is expected to come with a 4% increase in FY2012, but analysts expect that growth will accelerate to 12% in FY2013.

This article was written by

51.19K Followers

Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.

Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More.

Recommended For You

About MMLP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MMLP

Related Stocks

SymbolLast Price% Chg
MMLP
--